PATENT CLAIM ANALYSIS

Application Number: 15861789
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["424", "190100"]

Abstract:
The present invention relates to compositions comprising  Haemophilus influenzae  Protein E and Pilin A. More particularly, the present application relates to fusion proteins and immunogenic compositions comprising Protein E and PilA, vaccines comprising such immunogenic compositions and therapeutic uses of the same.

Claim (Index 2):
A method for the treatment of otitis media caused wholly or in part by non-typeable  Haemophilus influenzae  in a subject in need thereof comprising administering to said subject a therapeutically effective amount of an immunogenic composition comprising the fusion protein of SEQ ID NO. 219 (IQKAEQND VKLAPPTDVR SGYIRLVKNV NYYIDSESIW VDNQEPQIVH FDAVVNLDKG LYVYPEPKRY ARSVRQYKIL NCANYHLTQV RTDFYDEFWG QGLRAAPKKQ KKHTLSLTPD TTLYNAAQII CANYGEAFSV DKKGGTKKAA VSELLQASAP YKADVELCVY STNETTNCTG GKNGIAADIT TAKGYVKSVT TSNGAITVKG DGTLANMEYI LQATGNAATG VTWTTTCKGT DASLFPANFC GSVTQ).

Metadata:
- Claim Count in Document: 3.0
- Percentile: 86.0
- Lexical Diversity: 1.53333
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14571546', '15197952', '14110857', '13826696', '15119220']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7900481488684741
- 35 USC 102 Novelty (BERT): 0.6715964135706224
- Combined Prediction Score: 0.7782029753386889
- Mean Citation Score: 592.756764
- Max Citation Score: 693.05444
- Similarity Product: 639.193439135189

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test